Vi vil gerne bruge cookies til statistik og annoncer, også fra vores partnere. Du kan altid ændre dit valg.
Eloxx Pharmaceuticals · J36
Fra 1 stk.
60.000 brugere er allerede i gang
Markedsdata leveret af TwelveData og Morningstar
INVESTER I ELOXX PHARMACEUTICALS MED ENDAVU: Køb Eloxx Pharmaceuticals ($J36) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Eloxx Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.
Eloxx Pharmaceuticals, Inc. Common Stock represents equity in Eloxx Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel small-molecule medicines that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations. The company’s current pipeline centers on exaluren, which is being studied for rare kidney diseases such as nonsense mutation Alport syndrome and autosomal dominant polycystic kidney disease, along with related ultra-rare genetic conditions. Eloxx also has a licensed program, ZKN-013, being advanced for rare dermatological diseases associated with nonsense mutations. Headquartered in Arlington, Massachusetts, Eloxx Pharmaceuticals operates in the biotechnology sector and serves a specialized niche in precision therapies for rare and ultra-rare disorders.